For healthcare professionals. This information does not replace clinical judgement in the individual case; the current summary of product characteristics and the guidelines cited are authoritative.
Medically reviewed: Dr. med. univ. Daniel Pehböck, DESA, 01.11.2026
Naloxone (Opioid antagonist (µ, κ and δ receptors)) – indications: Opioid toxicity with respiratory depression – adults, Opioid toxicity – intranasal emergency use (ready-to-use spray, from 14 y), Opioid toxicity – children, Postoperative opioid-induced respiratory depression – adults. Weight-based dosing in mg and ml in the app, with sources.
Indications
- Opioid toxicity with respiratory depression – adults
- Opioid toxicity – intranasal emergency use (ready-to-use spray, from 14 y)
- Opioid toxicity – children
- Postoperative opioid-induced respiratory depression – adults
Complete in the app
Weight-based doses in mg and ml, preparations, contraindications and notes – in the app, also offline.
Used in
Sources and guidelines
- Summaries of product characteristics of authorised products – product and section for each dose in the app.